APA aipamena

Fazio, S., & Linton, M. F. (2009). Elevated High-Density Lipoprotein (HDL) Levels due to Hepatic Lipase Mutations Do Not Reduce Cardiovascular Disease Risk: Another Strike against the HDL Dogma. The Endocrine Society.

Chicago Style aipamena

Fazio, Sergio, and MacRae F. Linton. Elevated High-Density Lipoprotein (HDL) Levels Due to Hepatic Lipase Mutations Do Not Reduce Cardiovascular Disease Risk: Another Strike against the HDL Dogma. The Endocrine Society, 2009.

MLA aipamena

Fazio, Sergio, and MacRae F. Linton. Elevated High-Density Lipoprotein (HDL) Levels Due to Hepatic Lipase Mutations Do Not Reduce Cardiovascular Disease Risk: Another Strike against the HDL Dogma. The Endocrine Society, 2009.